To address non-compliance and improve the ratio of completed trials with results, we recommend the following two-step process to take control of your compliance.
As you evaluate clinical trial enrollment acceleration strategies, be sure to understand the root causes of slow enrollment and the reasons why traditional acceleration programs do not work.
Five common CDA pain points that can make a simple sounding agreement so challenging for clinical teams.
Five considerations to help organizations make better planning and forecasting decisions in an environment with such strict parameters.
With spiraling costs and increasing stakeholder demands, it’s critical that studies get off to the right start.
Workflow-based technology coupled with executive authoritative power encourages process optimization in the clinical trial continuum, helping to break down silos, enhance operational performance and ensure quality in the electronic trial master file.
How to employ processes that take an upfront approach to preventing or mitigating problems associated with document completion.
Why you should prepare now even with nearly a year remaining.
Since the launch of myTI—TransPerfect’s mobile experience for the Trial Interactive eTMF—I have heard rave reviews from clinical operations leaders and CRAs. The advantages of mobile technology for clinical operations are generating a lot of excitement, and rightfully so. In my collaboration with study teams during the development, release, and ongoing evolution of myTI, we encountered many thematic pain points that were ripe for a mobile solution.
An overview of the progress that has been made in pediatric drug development.
|
|
|
|
|
|
|
|
|